Cargando…

Intravenous Tissue Plasminogen Activator Can Be Safely Given without Complete Blood Count Results Back

INTRODUCTION: It is well known that the efficacy of intravenous (IV) tissue plasminogen activator (tPA) is time-dependent when used to treat patients with acute ischemic strokes. AIM: Our study examines the safety issue of giving IV tPA without complete blood count (CBC) resulted. MATERIALS AND METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Yi, Yang, Lumeng, Ren, Jinma, Nair, Deepak S., Parker, Sarah, Jahnel, Jan L., Swanson-Devlin, Teresa G., Beck, Judith M., Mathews, Maureen, McNeil, Clayton J., Ling, Yifeng, Cheng, Xin, Gao, Yuan, Dong, Qiang, Wang, David Z.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492952/ https://www.ncbi.nlm.nih.gov/pubmed/26147994 http://dx.doi.org/10.1371/journal.pone.0131234

Ejemplares similares

Vascular Risk Factors in Patients with Different Subtypes of Ischemic Stroke May Affect Their Outcome after Intravenous tPA
por: Dong, Yi, et al.
Publicado: (2015)

Low-dose intravenous tissue plasminogen activator for acute ischaemic stroke: an alternative or a new standard?
por: Dong, Yi, et al.
Publicado: (2016)

The predictive role of electrocardiographic abnormalities in ischemic stroke patients with intravenous thrombolysis
por: Wu, Fei, et al.
Publicado: (2014)

Seizures after intravenous tramadol given as premedication
por: Raiger, Lalit Kumar, et al.
Publicado: (2012)

Advice Given by Health Food Shops: Is It Clinically Safe?
por: Vickers, A J, et al.
Publicado: (1998)

Levels of soluble fibrin in severe septic patients given intravenous immunoglobulin
por: Kobayashi, T, et al.
Publicado: (2009)

Pharmacokinetic Study of Carboplatin Given on a 5‐Day Intravenous Schedule
por: Ando, Yuichi, et al.
Publicado: (1997)

The effect on post-operative pain of intravenous clonidine given before induction of anaesthesia
por: Samantaray, Aloka, et al.
Publicado: (2012)

Intravenous tissue plasminogen activator, ischemic stroke, and the risk of Kounis Syndrome
por: Kounis, Nicholas G., et al.
Publicado: (2011)

Is Bismuth Safe for Intravenous Use?
por: Thakkar, K. V.
Publicado: (1932)

P02-08 This has just given me life back’ – mixed method evaluation of the Wild Skills, Wild Spaces ecotherapy project, Wales, UK
por: Crone, Diane, et al.
Publicado: (2022)

The Effect of Calcium, Water, and Other Substances Given Intravenously on Blood Composition and Urinary Secretion
por: Davis, D. M.
Publicado: (1917)

Who may benefit from lower dosages of intravenous tissue plasminogen activator? Results from a cluster data analysis
por: Dong, Yi, et al.
Publicado: (2020)

Unruptured Cerebral Aneurysm Detected after Intravenous Tissue Plasminogen Activator for Stroke
por: Yoneda, Yukihiro, et al.
Publicado: (2009)

Medicolegal Considerations with Intravenous Tissue Plasminogen Activator in Stroke: A Systematic Review
por: Bhatt, Archit, et al.
Publicado: (2013)

Intravenous Tissue Plasminogen Activator for an Ischemic Stroke with Occult Double Primary Cancer
por: Yoneda, Yukihiro, et al.
Publicado: (2014)

An Efficient Algorithm to Count Tree-Like Graphs with a Given Number of Vertices and Self-Loops
por: Azam, Naveed Ahmed, et al.
Publicado: (2020)

Intravenous Tissue Plasminogen Activator Improves the Outcome in Very Elderly Korean Patients with Acute Ischemic Stroke
por: Choi, Jay Chol, et al.
Publicado: (2015)

Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis in a Patient with Acute Ischemic Stroke Secondary to Aortic Dissection
por: Hong, Keun-Sik, et al.
Publicado: (2009)

TOLERANCE TO AMINO ACID MIXTURES AND CASEIN DIGESTS GIVEN INTRAVENOUSLY : GLUTAMIC ACID RESPONSIBLE FOR REACTIONS
por: Madden, S. C., et al.
Publicado: (1945)

Cost Reduction of Inhaled Tobramycin by Use of Preservative-Free Intravenous Tobramycin Given via Inhalation
por: Gauthier, Timothy P., et al.
Publicado: (2015)

Intravenous injection of a novel viral immunotherapy encoding human interleukin-7 in nonhuman primates is safe and increases absolute lymphocyte count
por: Coupet, Charles-Antoine, et al.
Publicado: (2022)

Outcomes of Endovascular Mechanical Thrombectomy and Intravenous Tissue Plasminogen Activator for the Treatment of Vertebrobasilar Stroke
por: Brinjikji, Waleed, et al.
Publicado: (2014)

Evaluation of Cerebral Perfusion in Patients Undergoing Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis
por: HIRANO, Teruyuki
Publicado: (2015)

Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus schedule
por: Awada, A, et al.
Publicado: (1999)

SELECTIVE NECROSIS OF CARDIAC AND SKELETAL MUSCLE INDUCED EXPERIMENTALLY BY MEANS OF PROTEOLYTIC ENZYME SOLUTIONS GIVEN INTRAVENOUSLY
por: Kellner, Aaron, et al.
Publicado: (1954)

Assessment of cerebral circulation in a porcine model of intravenously given E. coli induced fulminant sepsis
por: Molnár, Levente, et al.
Publicado: (2017)

Intravenous Tranexamic Acid Given at Femoral Fragility Fracture Surgery Reduces Blood Transfusion Requirements Fourfold
por: Powell-Bowns, Matilda F. R., et al.
Publicado: (2023)

Is future given ?
por: Prigogine, Ilya
Publicado: (2003)

The effect of intravenous tissue-type plasminogen activator in a rat model of embolic cerebral ischemia.
por: Penar, P. L., et al.
Publicado: (1987)

Racial Disparities in Intravenous Recombinant Tissue Plasminogen Activator Use Persist at Primary Stroke Centers
por: Aparicio, Hugo J., et al.
Publicado: (2015)

Intravenous recombinant tissue plasminogen activator for acute ischemic stroke: a feasibility and safety study
por: Sadeghi-Hokmabadi, Elyar, et al.
Publicado: (2016)

Homocystinuria with Cerebral Venous Sinus Thrombosis: Excellent Recovery with Intravenous Recombinant Tissue Plasminogen Activator
por: Gowda, Vykuntaraju K, et al.
Publicado: (2017)

Predictors of Intracerebral Hemorrhage in Acute Stroke Patients Receiving Intravenous Recombinant Tissue Plasminogen Activator
por: Chenna, Vijay, et al.
Publicado: (2018)

Intravenous tissue plasminogen activator for ischemic stroke in early pregnancy dosed by actual body weight
por: Peksa, Gary D, et al.
Publicado: (2019)

Plasminogen
por: Kline, Daniel L.
Publicado: (1954)

A glutamine containing dipeptide in high concentration may be given safely via the peripheral route in ICU-patients
por: Berg, A, et al.
Publicado: (2001)

Safe Use of Tissue Plasminogen Activator in Conjunction with the Integra Camino Bolt for the Drainage of Chronic Subdural Hematoma
por: Doan, Ninh B., et al.
Publicado: (2018)

Tissue plasminogen activator and pulmozyme for postoperative-retained hemothorax: A safe alternative to postoperative re-exploration
por: Pastoressa, Melissa, et al.
Publicado: (2017)

Contrast-induced nephropathy and allergic reaction in patients who were given intravenous contrast material in emergency department
por: Caltekin, İbrahim, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cdpifk09fk767uj2u16mvdnerj